GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$81.52
−6.41%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$87.73
From 52W high−15.80%
Volume3.88M
Market cap$10.95B
P/E (TTM)20.5x
P/S (TTM)3.5x
Div yield—
Key dataNov 5, 2026
Open
$87.73
From 52W high
−15.80%
Volume
3.88M
Market cap
$10.95B
ValuationView details →
P/E (Fwd)
15.6x
EV/EBITDA
11.1x
P/E (TTM)
20.5x
RSI (14)
54.6
MomentumView details →
1D Return
−6.41%
YTD Return
−6.37%
SummaryUpdated Sep 1, 2026
Globus Medical, Inc. (NYSE:GMED) is a medical device company founded in 2003 and headquartered in Audubon, Pennsylvania. The company went public in 2012 and has grown through both organic expansion and strategic acquisitions to become a major player in the musculoskeletal medical device market. In September 2023, Globus completed a transformative merger with NuVasive, significantly expanding its product portfolio and global reach. The company has evolved from a spine-focused specialist into a comprehensive musculoskeletal solutions provider, offering products for spine, trauma, orthopedics, and enabling technologies including robotic surgical systems.
Similar companies
Latest newsMore news →
GLOBUS MEDICAL INC reported quarterly earnings of $1.23 per share, compared with $1.18 per share a year earlier.12h agoGlobus Medical reported financial results for the third quarter ended September 30, 2026; the results were not specified.15h agoGlobus Medical announced a $500 million increase to its share repurchase program.15h ago